Brenda Huneycutt to Moderate FDA Panel at the 2014 Biotech Showcase in San Francisco
Summary
Join Avalere's Brenda Huneycutt, FDA Policy & Regulatory Strategy Practice, who will be moderating a panel with Avalere's Jenny Gaffney and other leading experts at the Biotech Showcase in San Francisco on Tuesday, January 14th at 8am, titled "FDA: where it's going and how it affects biotech."
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
Brenda’s panel will focus on FDA’s four programs intended to speed up drug sponsors’ drug development and regulatory review processes for therapies treating serious conditions. The programs, called “expedited programs,” include: fast track, priority review, accelerated approval, and breakthrough therapy designation. Brenda’s panel will explore how these programs are changing biotech, what the benefits of these programs are, how they increase a product’s value, and how to apply for these programs.
Hope to see everyone in January.
Click here for more information on the 2014 Biotech Showcase.
Listen to a preview of the session here:
Rare Disease Day Webinar: Voices that move systems
Access the webinar replay offering actionable, cross-geography insights on how patient and caregiver voices can improve diagnosis, engagement, and outcomes.
Replay